$SSY
SUNLINK HEALTH SYSTEMS INC

2018 Q2 Form 10-Q Financial Statement

#000119312518160263 Filed on May 11, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2018 Q1 2017 Q1
Revenue $12.21M $13.42M $13.70M
YoY Change -0.6% -2.06% -15.46%
Cost Of Revenue $3.906M $672.0K $692.0K
YoY Change -9.79% -2.89% -9.07%
Gross Profit $8.308M $12.75M $13.01M
YoY Change 4.37% -2.01% -15.78%
Gross Profit Margin 68.02% 94.99% 94.95%
Selling, General & Admin $7.380M $5.819M $7.290M
YoY Change 1.37% -20.18% -21.95%
% of Gross Profit 88.83% 45.66% 56.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $526.0K $383.0K $470.0K
YoY Change -2.59% -18.51% -2.08%
% of Gross Profit 6.33% 3.01% 3.61%
Operating Expenses $9.392M $6.980M $8.950M
YoY Change 0.56% -22.01% -24.02%
Operating Profit -$1.084M -$720.0K -$771.0K
YoY Change -21.45% -6.61% -35.05%
Interest Expense -$57.00K $56.00K $129.0K
YoY Change -56.15% -56.59% -38.86%
% of Operating Profit
Other Income/Expense, Net $1.190M
YoY Change -39.29%
Pretax Income -$1.153M -$593.0K -$898.0K
YoY Change -62.07% -33.96% -35.53%
Income Tax -$49.00K $0.00 -$8.000K
% Of Pretax Income
Net Earnings -$1.454M -$588.0K -$1.025M
YoY Change -39.62% -42.63% -44.14%
Net Earnings / Revenue -11.9% -4.38% -7.48%
Basic Earnings Per Share -$0.08 -$0.11
Diluted Earnings Per Share -$195.4K -$0.08 -$0.11
COMMON SHARES
Basic Shares Outstanding 7.417M shares 7.417M 9.334M shares
Diluted Shares Outstanding 7.417M 9.334M shares

Balance Sheet

Concept 2018 Q2 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.456M $3.541M $11.20M
YoY Change -67.09% -68.38% 187.18%
Cash & Equivalents $3.456M $3.541M $11.24M
Short-Term Investments
Other Short-Term Assets $2.937M $3.083M $3.800M
YoY Change -28.37% -18.87% 58.33%
Inventory $1.854M $1.974M $2.171M
Prepaid Expenses
Receivables $4.823M $5.884M $6.300M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $13.11M $14.48M $23.49M
YoY Change -42.05% -38.35% 27.6%
LONG-TERM ASSETS
Property, Plant & Equipment $5.896M $10.54M $10.68M
YoY Change -42.7% -1.3% -51.12%
Goodwill $461.0K
YoY Change 0.0%
Intangibles $1.470M $1.500M $2.589M
YoY Change -7.37% -42.06% -5.2%
Long-Term Investments
YoY Change
Other Assets $885.0K $969.0K $908.0K
YoY Change 5.61% 6.72% -37.94%
Total Long-Term Assets $13.07M $13.31M $14.64M
YoY Change 2.76% -9.1% -44.77%
TOTAL ASSETS
Total Short-Term Assets $13.11M $14.48M $23.49M
Total Long-Term Assets $13.07M $13.31M $14.64M
Total Assets $26.18M $27.79M $38.13M
YoY Change -25.92% -27.12% -15.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.239M $1.254M $1.851M
YoY Change -21.13% -32.25% -62.79%
Accrued Expenses $290.0K $293.0K $630.0K
YoY Change -55.93% -53.49% -41.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $255.0K $258.0K $503.0K
YoY Change -96.2% -48.71% -93.81%
Total Short-Term Liabilities $4.851M $5.285M $6.640M
YoY Change -60.61% -20.41% -65.16%
LONG-TERM LIABILITIES
Long-Term Debt $2.803M $2.863M $6.327M
YoY Change -54.75% 90.51%
Other Long-Term Liabilities $340.0K $304.0K $283.0K
YoY Change 17.65% 7.42% -50.0%
Total Long-Term Liabilities $4.139M $3.919M $7.489M
YoY Change 211.44% -47.67% 46.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.851M $5.285M $6.640M
Total Long-Term Liabilities $4.139M $3.919M $7.489M
Total Liabilities $8.990M $9.204M $14.13M
YoY Change -34.11% -34.86% -41.52%
SHAREHOLDERS EQUITY
Retained Earnings $2.743M $4.197M $6.744M
YoY Change -36.74% -37.77% 134.0%
Common Stock $14.62M $14.72M $17.68M
YoY Change -17.33% -16.76% -3.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.19M $18.59M $24.00M
YoY Change
Total Liabilities & Shareholders Equity $26.18M $27.79M $38.13M
YoY Change -25.92% -27.12% -15.11%

Cashflow Statement

Concept 2018 Q2 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$1.454M -$588.0K -$1.025M
YoY Change -39.62% -42.63% -44.14%
Depreciation, Depletion And Amortization $526.0K $383.0K $470.0K
YoY Change -2.59% -18.51% -2.08%
Cash From Operating Activities $429.0K -$303.0K -$1.090M
YoY Change -170.33% -72.2% -273.02%
INVESTING ACTIVITIES
Capital Expenditures -$359.0K $278.0K $289.0K
YoY Change -32.26% -3.81% -4.3%
Acquisitions
YoY Change
Other Investing Activities $13.00K $412.0K $0.00
YoY Change -97.59%
Cash From Investing Activities -$346.0K -$20.00K -$280.0K
YoY Change -92.86% -17.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -168.0K 900.0K -1.770M
YoY Change 20.0% -150.85% 1261.54%
NET CHANGE
Cash From Operating Activities 429.0K -303.0K -1.090M
Cash From Investing Activities -346.0K -20.00K -280.0K
Cash From Financing Activities -168.0K 900.0K -1.770M
Net Change In Cash -85.00K 577.0K -3.140M
YoY Change -88.67% -118.38% -2062.5%
FREE CASH FLOW
Cash From Operating Activities $429.0K -$303.0K -$1.090M
Capital Expenditures -$359.0K $278.0K $289.0K
Free Cash Flow $788.0K -$581.0K -$1.379M
YoY Change -1085.0% -57.87% -520.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Assets
Assets
38133000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11237000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
545000
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
569000
CY2018Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
293000
CY2018Q1 us-gaap Assets Current
AssetsCurrent
14482000
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19559000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3541000
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7417000 shares
CY2018Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7416814 shares
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
732000
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
710000
CY2018Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11009000
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1254000
CY2018Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
6453000
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-327000
CY2018Q1 us-gaap Assets
Assets
27791000
CY2018Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
0
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7417000 shares
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
3708000
CY2018Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8071000
CY2018Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2381000
CY2018Q1 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
296000
CY2018Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1500000
CY2018Q1 us-gaap Inventory Net
InventoryNet
1974000
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27791000
CY2018Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3919000
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5285000
CY2018Q1 us-gaap Long Term Debt
LongTermDebt
3347000
CY2018Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
258000
CY2018Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2863000
CY2018Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2765000
CY2018Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
304000
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2018Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1099000
CY2018Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
13400000
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
969000
CY2018Q1 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000 shares
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3083000
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10544000
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
30103000
CY2018Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
5884000
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4197000
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
18587000
CY2018Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
226000
CY2018Q1 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
752000
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
991000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3261000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
552000
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
658000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
22621000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18319000
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
13103000
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1571000
CY2017Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
6458000
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-327000
CY2017Q2 us-gaap Assets
Assets
35336000
CY2017Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
12000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10494000
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9163000 shares
CY2017Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9163000 shares
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
4581000
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2098000
CY2017Q2 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
0
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1587000
CY2017Q2 us-gaap Inventory Net
InventoryNet
2159000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35336000
CY2017Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1329000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12314000
CY2017Q2 us-gaap Long Term Debt
LongTermDebt
7203000
CY2017Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6710000
CY2017Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2017Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2425000
CY2017Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1277000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
838000
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
289000
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2017Q2 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000 shares
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3062000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10290000
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28609000
CY2017Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
5906000
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1000000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4336000
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
21693000
CY2017Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
493000
CY2017Q2 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
1040000
ssy Net Operating Loss Carryforward Expiration Year
NetOperatingLossCarryforwardExpirationYear
2025
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
59000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1322000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
106000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7976000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5096000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-221000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
15592000
us-gaap Cost Of Services
CostOfServices
2113000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-15000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1376000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
6937000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
4287000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
2650000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.54
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-243000
us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
321000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
3019000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
809000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.09
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.46
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
141000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
573000
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.09
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.45
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-236000
us-gaap Interest Expense
InterestExpense
507000
us-gaap Interest Paid
InterestPaid
458000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
17476000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-139000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-296000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18465000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5490000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4999000
us-gaap Net Income Loss
NetIncomeLoss
5096000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1696000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
409000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4015000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
640000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1097000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
14620000
us-gaap Proceeds From Sale Of Other Assets1
ProceedsFromSaleOfOtherAssets1
4942000
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
-1000000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
342000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3850000
us-gaap Sales Revenue Net
SalesRevenueNet
41000000
us-gaap Supplies Expense
SuppliesExpense
1373000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9429000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9408000 shares
ssy Financial And Healthcare Services Revenue
FinancialAndHealthcareServicesRevenue
41321000
ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
1097000
ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
0
dei Amendment Flag
AmendmentFlag
false
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
793000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
87000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6953000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
14623000
us-gaap Cost Of Services
CostOfServices
2021000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1332000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-110000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-110000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Type
DocumentType
10-Q
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
0
dei Document Period End Date
DocumentPeriodEndDate
2018-03-31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
dei Entity Registrant Name
EntityRegistrantName
SUNLINK HEALTH SYSTEMS INC
dei Entity Central Index Key
EntityCentralIndexKey
0000096793
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
944000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-238000
us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
363000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
181000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-29000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-325000
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-296000
us-gaap Interest Expense
InterestExpense
302000
us-gaap Interest Paid
InterestPaid
269000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
17697000
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>Note 4. &#x2013; Economic Damages Claim</b></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The Pharmacy Segment subsidiary asserted claims for economic damages in connection with the Deepwater Horizon Settlement Program related to the event which occurred in 2010. In January 2018, these claims were settled and payments of approximately $944&#xA0;(net of costs and attorneys&#x2019; fees) were received. The net settlements are recognized as a gain in the Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss) for the nine months ended March&#xA0;31, 2018.</p> </div>
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 2. &#x2013; Business Operations</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <u>Business Operations</u></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> SunLink Health Systems, Inc., through subsidiaries, owns businesses which provide healthcare products and services in certain markets in the southeastern United States. Our business is composed of two segments, the Healthcare Services segment and the Pharmacy segment. Our Healthcare Services segment subsidiaries own and operate an <font style="WHITE-SPACE: nowrap">84-bed</font> community hospital and a <font style="WHITE-SPACE: nowrap">66-bed</font> nursing home in Mississippi, a <font style="WHITE-SPACE: nowrap">100-bed</font> nursing home in Georgia, an IT service company, and healthcare facilities which are leased to third parties. Our Pharmacy segment subsidiary operates a pharmacy business in Louisiana with four service lines.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The business strategy of SunLink is to focus its efforts on expanding the services and improving the operations and profitability of its existing Healthcare Services and Pharmacy businesses. The Company is investing in upgrades and improvements to certain of its Healthcare Services and Pharmacy businesses, while seeking to sell certain of its subsidiaries&#x2019; underperforming assets.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The Company has used a portion of the cash proceeds from recent dispositions of assets to pay down debt and certain other liabilities, and to repurchase common shares in tender offers completed in February and December 2017. The Company may also use existing cash, as well as any net proceeds from future dispositions, if any, to improve its existing businesses, make acquisitions of Healthcare Services and Pharmacy businesses, prepay debts, return capital to shareholders including through potential public or private purchases of shares, and for other general corporate purposes. There is no assurance that any further dispositions will be authorized by the Company&#x2019;s Board of Directors or, if authorized, that any such transactions will be completed or, if completed, will result in net cash proceeds to the Company on a before or after tax basis.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The Company considers the disposition of business segments, facilities and operations based on a variety of factors in addition to under-performance, including asset values, return on investments, competition from existing and potential competitors, capital improvement needs, the prevailing reimbursement environment under various Federal and state programs (e.g., Medicare and Medicaid) and private payors, and other corporate objectives. The Company believes certain facilities in its Healthcare Services segment as well as its Pharmacy segment continue to under-perform, and the Company has engaged advisors to assist it in evaluating the possible sale of its Pharmacy business lines.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> On January&#xA0;11, 2018, Carmichael&#x2019;s Cashway Pharmacy, Inc., a wholly owned subsidiary of the Company, sold the assets of a retail pharmacy operation for approximately $410. A <font style="WHITE-SPACE: nowrap">pre-tax</font> gain of $183 on the sale of these assets is included in the results for the three months ended March&#xA0;31, 2018.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"> Throughout these notes to the consolidated financial statements, all references to &#x201C;SunLink,&#x201D; &#x201C;we,&#x201D; &#x201C;our,&#x201D; &#x201C;ours,&#x201D; &#x201C;us&#x201D; and the &#x201C;Company&#x201D; refer to SunLink Health Systems, Inc. and our consolidated subsidiaries. References to our specific operations refer to operations conducted through our subsidiaries and references to &#x201C;we,&#x201D; &#x201C;our,&#x201D; &#x201C;ours,&#x201D; and &#x201C;us&#x201D; in such context refer to the operations.</p> </div>
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1090000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5830000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33000
us-gaap Net Income Loss
NetIncomeLoss
-139000
us-gaap Operating Income Loss
OperatingIncomeLoss
-910000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
471000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3639000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2974000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1502000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
us-gaap Proceeds From Sale Of Other Assets1
ProceedsFromSaleOfOtherAssets1
412000
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
1000000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
445000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3856000
us-gaap Sales Revenue Net
SalesRevenueNet
40658000
us-gaap Supplies Expense
SuppliesExpense
1361000
dei Trading Symbol
TradingSymbol
SSY
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8564000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8564000 shares
ssy Financial And Healthcare Services Revenue
FinancialAndHealthcareServicesRevenue
41021000
ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
1502000
ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
21000
ssy Accrued Penalty Expense
AccruedPenaltyExpense
170000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5000
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
318000
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1025000
CY2017Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-32000
CY2017Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5523000
CY2017Q1 us-gaap Cost Of Services
CostOfServices
692000
CY2017Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
24000
CY2017Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
466000
CY2017Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-210000
CY2017Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-135000
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2017Q1 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
-75000
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2017Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
CY2017Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2017Q1 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
184000
CY2017Q1 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
2000
CY2017Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-890000
CY2017Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.10
CY2017Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-898000
CY2018Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2018Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
464000
CY2017Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.10
CY2017Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8000
CY2017Q1 us-gaap Interest Expense
InterestExpense
129000
CY2017Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5872000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-1025000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-771000
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2017Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
142000
CY2017Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1194000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
289000
CY2017Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
126000
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
13699000
CY2017Q1 us-gaap Supplies Expense
SuppliesExpense
455000
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9334000 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9334000 shares
CY2017Q1 ssy Financial And Healthcare Services Revenue
FinancialAndHealthcareServicesRevenue
13883000
CY2017Q1 ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
0
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1000
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
342000
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-588000
CY2018Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5073000
CY2018Q1 us-gaap Cost Of Services
CostOfServices
672000
CY2018Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
16000
CY2018Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
16000
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2018Q1 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
0
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2018Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0
CY2018Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2018Q1 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
133000
CY2018Q1 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
183000
CY2018Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-604000
CY2018Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.08
CY2018Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-604000
CY2018Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.08
CY2018Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018Q1 us-gaap Interest Expense
InterestExpense
56000
CY2018Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6045000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-588000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-731000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2018Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
157000
CY2018Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1052000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
430000
CY2018Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
237000
CY2018Q1 us-gaap Sales Revenue Net
SalesRevenueNet
13417000
CY2018Q1 us-gaap Supplies Expense
SuppliesExpense
448000
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7417000 shares
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7417000 shares
CY2018Q1 ssy Financial And Healthcare Services Revenue
FinancialAndHealthcareServicesRevenue
13550000
CY2018Q1 ssy Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss
HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss
0
ssy Number Of Hospitals Sold
NumberOfHospitalsSold
3 Hospital

Files In Submission

Name View Source Status
0001193125-18-160263-index-headers.html Edgar Link pending
0001193125-18-160263-index.html Edgar Link pending
0001193125-18-160263.txt Edgar Link pending
0001193125-18-160263-xbrl.zip Edgar Link pending
d766736d10q.htm Edgar Link pending
d766736dex311.htm Edgar Link pending
d766736dex312.htm Edgar Link pending
d766736dex321.htm Edgar Link pending
d766736dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssy-20180331.xml Edgar Link completed
ssy-20180331.xsd Edgar Link pending
ssy-20180331_cal.xml Edgar Link unprocessable
ssy-20180331_def.xml Edgar Link unprocessable
ssy-20180331_lab.xml Edgar Link unprocessable
ssy-20180331_pre.xml Edgar Link unprocessable